Clinithink

Clinithink is a technology and artificial intelligence services company, founded in 2009, with bases in the United States and in the United Kingdom. Clinithink patented an artificial intelligence program they developed called CLiX. CLiX is a language processing program that combs unstructured medical patient charts and returns the data to the system with structure.

Clinithink was developed due to lack of conformity in medical charting practices.

Clinithink currently holds an Early Stage Venture funding status. Their last funding round was a Series B funding round that raised an unspecified amount of money in 2019. The previous funding rounds that were classified as Series A, took place in April & July of 2012. The lead investors in Clinithink are Merck and TT Capital Partners, however Vanguard Atlantic and Development Bank of Wales also made investments in the Series A - Clinithink Funding Round.

Clinithink is a technology and services company focused on using Artificial Intelligence to deliver data insights for life science and healthcare.